OHE holds a variety of events each year, including

  • lunchtime seminars 
  • expert seminars and workshops
  • collaborative seminars, workshops and conferences held jointly with other organisations
  • annual lecture

Outputs from our events generally are available in summary on our blog and/or as publications.

We welcome suggestions for seminar topics and opportunities for collaboration.

Event date:
Monday, 22 September 2014

Health care reforms in England during the last decade have been influenced by the idea that encouraging competition between hospitals, but with prices fixed nationally, will increase the quality of care for patients. A principal criticism of existing empirical studies is how they measure quality of care.

Event date:
Thursday, 17 July 2014

Decision making in health technology appraisal involves a significant degree of uncertainty as to the costs and benefits of the technology in question and the value of the expenditure displaced if it is approved. Based on his current research, Adrian Towse reviewed evidence at this seminar that suggests that decision makers react negatively to uncertainty about a technology’s costs and benefits and consider a range of potential theoretical justifications for this behaviour.

Event date:
Monday, 9 June 2014

Health services available to the entire population free of charge, and providing the best health advice and treatment, was the foundation stone for the creation of the National Health Service. The health systems of most other high income countries similarly embody the ideal of universal health coverage. Yet low- and lower-middle-income countries have recently been on the receiving end of global policies that have emphasised highly selective goals, in contrast to the initial broad themes of the Primary Health Care movement founded in Alma Ata in 1975 and pursued through WHO’s slogan Health for All.

Event date:
Wednesday, 23 April 2014

Many stakeholders agree that the current business model for antibiotics is broken. Antibiotic innovation has slowed and many of the drugs on the market are losing effectiveness because of resistance. Professor Kevin Outterson is working at Chatham House on evaluating alternatives that will promote both innovation and long-term sustainability of this valuable resource.